Related Experiment Video
Updated: Oct 7, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Infrequent occurrence of silent HBV infection among Indian patients with chronic liver disease
S Radhakrishnan1, P Abraham, S Raghuraman
1Department of Clinical Virology, Christian Medical College and Hospital, Vellore.
Insights
Silent hepatitis B virus (HBV) infection is rare in Indian patients with chronic liver disease (CLD). This study found no association between silent HBV infection and hepatitis C virus (HCV)-related CLD.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Chronic liver disease (CLD) is a significant global health concern.
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of CLD.
- Silent HBV infection, defined as HBV DNA presence without HBsAg, requires further investigation in endemic regions.
Purpose of the Study:
- To determine the prevalence of silent HBV infection in patients diagnosed with CLD in India.
- To explore the potential association between silent HBV infection and co-infection with HCV.
Main Methods:
- Plasma samples from 71 CLD patients were analyzed.
- Nested polymerase chain reaction (nPCR) was used to detect HBV DNA.
- HBV serum markers (HBsAg, anti-HBc, HBeAg, anti-HBe) and HCV markers (HCV RNA, anti-HCV) were quantified.
Main Results:
- Silent HBV infection was detected in 3.2% (2 out of 62) of HBsAg-negative CLD patients.
- No cases of silent HBV infection were observed in patients with evidence of HCV infection (26 patients).
- One HBsAg-positive patient showed anti-HCV positivity without detectable HCV RNA.
Conclusions:
- The rate of silent HBV infection among CLD patients in India is low.
- Silent HBV infection does not appear to be associated with HCV-related CLD in this cohort.
- Findings contrast with reports from other Asian HBV-endemic areas, suggesting regional variations.
Objective:
To investigate the occurrence of silent hepatitis B virus (HBV) infection among patients with chronic liver disease (CLD).
Methods:
Plasma samples from 71 CLD patients including 9 HBsAg-positive individuals were tested for HBV DNA by nested polymerase chain reaction (nPCR), and for HBV serum markers, i.e., anti-HBc antibody, HBeAg and anti-HBe antibody. The individuals were also tested for hepatitis C virus (HCV) RNA and anti-HCV antibody.
Results:
Among 62 HBsAg-negative patients, silent HBV infection was seen in only two (3.2%). Silent HBV infection was not found in any of the 26 patients who had evidence of HCV infection. One HBsAg-positive patient was positive for anti-HCV in the absence of HCV RNA.
Conclusions:
There is a low rate of silent HBV infection among patients with CLD in India, where HBV is moderately endemic. Silent HBV infection is not associated with HCV-related CLD, which is in contrast to reports from other HBV-endemic areas in Asia.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Genital Herpes
Cytomegalovirus Disease